BILLINGS, MT, September 23, 2010
/24-7PressRelease/ -- This new service focuses on online patient conversations and tracks relevant social media discussions surrounding a given therapeutic area. The centerpiece of this service is a report that features a customized dashboard, unique analytics illustrating shifts in drug buzz and patient sentiment, and a detailed analysis of relevant trending topics.
"Our team has spent the last 18 months working closely with top pharmaceutical companies to refine and validate our methodology in the area of social media monitoring," said company founder Bruno Larvol. "I am delighted to formally launch our service at the Pharma CI conference. The timing is perfect - our clients are currently exploring the best ways to leverage social media in their competitive intelligence and market research."
The Larvol Group, LLC, (www.larvol.com) founded in 2004, provides innovative business intelligence services for the pharmaceutical industry. Their Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, metabolic diseases, CNS, inflammation, and pain management. Their clients include nine of the top ten pharmaceutical companies.
For more information regarding this topic or to schedule an interview with Bruno Larvol, please contact Ramona Roof at ramona.roof@larvol.com at 415.874.3310
BLaST creative is a full-service marketing studio providing custom print and Web graphic images, banners, logo design, web design, search engine marketing and professional writing for all types of business.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Brenda Segna:
